Enrique D Eveline

Title: Enrique D. Eveline: Inventor of Sustained-Release Drug Dosage Technologies

Introduction

Enrique D. Eveline is an inventor associated with Waukegan, Illinois, and Abbott Laboratories Corporation. His patent work focuses on sustained-release drug dosage units designed to deliver medication gradually and maintain therapeutically effective levels in patients. His record includes 2 patents.

Latest Patents

Eveline’s listed patents, “Sustained-release drug dosage units of terazosin” and “Sustained-release drug dosage units,” describe a sustained-release coating made with ethylcellulose and/or methacrylic methylester, along with a plasticizer and a detackifying agent. The process coats sized drug granules with this composition, then combines them with a polymeric composition containing at least one viscosity agent to form dosage units.

The resulting dosage units are designed to release medication continuously and slowly, supporting a therapeutically effective dosage level after administration. The terazosin patent applies this approach specifically to dosage units containing terazosin.

Career Highlights

Eveline’s listed invention work addresses a pharmaceutical formulation challenge: controlling how quickly a drug is released from a dosage unit. The described coating and polymeric components provide a method for producing sustained-release formulations.

Collaborations

Eveline is listed in connection with Abbott Laboratories Corporation. Dale R. Brinker is identified as a coworker.

Conclusion

Enrique D. Eveline’s patent work centers on sustained-release drug dosage technologies that combine coated drug granules and polymeric materials to support gradual medication delivery.